MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century

References

• Jemal A, Siegel R, Ward E et al. Cancer statistics. CA Cancer J. Clin.57(1), 43–66 (2007).
   PubMed Web of Science ®Google Scholar
• Matushansky I, Maki RG. Mechanisms of sarcomagenesis. Hematol. Oncol. Clin. North Am.19(3), 427–449 (2005).
   PubMedGoogle Scholar
• Mertens F, Stromberg U, Mandahl N et al. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the chromosomes and morphology (CHAMP) study group. Cancer Res.62(14), 3980–3984 (2002).
   PubMedGoogle Scholar
• Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer7(4), 233–245 (2007).
   PubMed Web of Science ®Google Scholar
• Shing DC, McMullan DJ, Roberts P et al. FUS/ERG gene fusions in Ewing’s tumors. Cancer Res.63(15), 4568–4576 (2003).
   PubMed Web of Science ®Google Scholar
• Rubin BP, Schuetze SM, Eary JF et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol.20(17), 3586–3591 (2002).
   PubMed Web of Science ®Google Scholar
• Brisset S, Schleiermacher G, Peter M et al. CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases. Cancer Genet. Cytogenet.130(1), 57–61 (2001).
   PubMedGoogle Scholar
• Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat. Genet.34(4), 369–376 (2003).
   PubMed Web of Science ®Google Scholar
• Jerusalem G, Rorive A, Ancion G, Hustinx R, Fillet G. Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations. Ann. Oncol.17(Suppl. 10), 168–176 (2006).
   Google Scholar
• Dennis JL, Hvidsten TR, Wit EC et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin. Cancer Res.11(10), 3766–3772 (2005).
   PubMed Web of Science ®Google Scholar
• Sarcoma meta-analysis collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma meta-analysis collaboration. Lancet350(9092), 1647–1654 (1997).
   PubMed Web of Science ®Google Scholar
• Sarcoma meta-analysis collaboration. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma meta-analysis collaboration (SMAC). Cochrane Database Syst. Rev.2, CD001419 (2000).
   Google Scholar
• Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer16, 331–344 (1963).
   PubMed Web of Science ®Google Scholar
• Enjoji M, Hashimoto H, Tsuneyoshi M, Iwasaki H. Malignant fibrous histiocytoma: a clinicopathologic study of 130 cases. Acta Pathol. Jpn30(5), 727–741 (1980).
   PubMedGoogle Scholar
• Kearney MM, Soule EH, Ivins JC. Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer45(1), 167–178 (1980).
   PubMed Web of Science ®Google Scholar
• Weiss SW. Malignant fibrous histiocytoma: a reaffirmation. Am. J. Surg. Pathol.6(8), 773–784 (1982).
   PubMed Web of Science ®Google Scholar
• Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer41(6), 2250–2266 (1978).
   PubMed Web of Science ®Google Scholar
• Enzinger FM. Malignant fibrous histiocytoma 20 years after Stout. Am. J. Surg. Pathol.10(Suppl. 1), 43–53 (1986).
   PubMed Web of Science ®Google Scholar
• Dehner LP. Malignant fibrous histiocytoma: nonspecific morphologic pattern, specific pathologic entity, or both? Arch. Pathol. Lab. Med.112(3), 236–237 (1988).
   PubMedGoogle Scholar
• Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am. J. Surg. Pathol.16(3), 213–228 (1992).
   PubMed Web of Science ®Google Scholar
• Daugaard S. Current soft-tissue sarcoma classifications. Eur. J. Cancer40(4), 543–548 (2004).
   PubMed Web of Science ®Google Scholar
• Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology48(1), 3–12 (2006).
   PubMed Web of Science ®Google Scholar
• Tos AP. Classification of pleomorphic sarcomas: where are we now? Histopathology48(1), 51–62 (2006).
   PubMed Web of Science ®Google Scholar
• Rouhani P, Fletcher CD, Devesa SS, Toro JR. Cutaneous soft tissue sarcoma incidence patterns in the USA: an analysis of 12,114 cases. Cancer113(3), 616–627 (2008).
   PubMed Web of Science ®Google Scholar
• Murphey MD. World Health Organization classification of bone and soft tissue tumors: modifications and implications for radiologists. Semin. Musculoskelet. Radiol.11(3), 201–214 (2007).
   PubMedGoogle Scholar
• Randall RL, Albritton KH, Ferney BJ, Layfield L. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis. Am. J. Orthop.33(12), 602–608 (2004).
   PubMedGoogle Scholar
• Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch. Pathol. Lab. Med.131(8), 1267–1280 (2007).
   PubMed Web of Science ®Google Scholar
• Sesterhenn IA, Davis CJ Jr. Pathology of germ cell tumors of the testis. Cancer Control11(6), 374–387 (2004).
   PubMedGoogle Scholar
• Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med.319(9), 525–532 (1988).
   PubMed Web of Science ®Google Scholar
• Pierce GB, Johnson LD. Differentiation and cancer. In Vitro7(3), 140–145 (1971).
   PubMedGoogle Scholar
• Orfao A, Schmitz G, Brando B et al. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin. Chem.45(10), 1708–1717 (1999).
   PubMed Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views. Stem cells25(11), 2896–2902 (2007).
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H, Gay RE, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood56(2), 289–301 (1980).
   PubMed Web of Science ®Google Scholar
• Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell. Mol. Med.8(3), 301–316 (2004).
   PubMed Web of Science ®Google Scholar
• Gazziola C, Cordani N, Wasserman B et al. Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts. Int. J. Oncol.23(2), 343–351 (2003).
   PubMedGoogle Scholar
• Smith JR, Pochampally R, Perry A, Hsu SC, Prockop DJ. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells22(5), 823–831 (2004).
   PubMed Web of Science ®Google Scholar
• Segal NH, Pavlidis P, Antonescu CR et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am. J. Pathol.163(2), 691–700 (2003).
   PubMed Web of Science ®Google Scholar
• Matushansky I, Hernando E, Socci ND et al. A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. Am. J. Pathol.172(4), 1069–1080 (2008).
   PubMed Web of Science ®Google Scholar
• Matushansky I, Hernando E, Socci ND et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J. Clin. Invest.117(11), 3248–3257 (2007).
   PubMed Web of Science ®Google Scholar
• Eckfeldt CE, Mendenhall EM, Verfaillie CM. The molecular repertoire of the ‘almighty’ stem cell. Nat. Rev. Mol. Cell Biol.6(9), 726–737 (2005).
   PubMed Web of Science ®Google Scholar
• Rao RR, Stice SL. Gene expression profiling of embryonic stem cells leads to greater understanding of pluripotency and early developmental events. Biol. Reprod.71(6), 1772–1778 (2004).
   PubMedGoogle Scholar
• Tasso R, Augello A, Carida M et al. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis30(1), 150–157 (2009).
   PubMedGoogle Scholar
• Yamate J, Ogata K, Yuasa T et al. Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells. Eur. J. Cancer43(18), 2747–2756 (2007).
   PubMedGoogle Scholar
• Gregory CA, Singh H, Perry AS, Prockop DJ. The Wnt signaling inhibitor Dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem.278(30), 28067–28078 (2003).
   PubMed Web of Science ®Google Scholar
• Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell8(5), 727–738 (2005).
   PubMed Web of Science ®Google Scholar
• Glass DA, Bialek P, Ahn JD et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell8(5), 751–764 (2005).
   PubMed Web of Science ®Google Scholar
• Lee N, Smolarz AJ, Olson S et al. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies. Br. J. Cancer97(11), 1552–1559 (2007).
   PubMed Web of Science ®Google Scholar
• Longo KA, Wright WS, Kang S et al. Wnt10b inhibits development of white and brown adipose tissues. J. Biol. Chem.279(34), 35503–35509 (2004).
   PubMed Web of Science ®Google Scholar
• Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J. Clin. Invest.116(5), 1202–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Ross SE, Hemati N, Longo KA et al. Inhibition of adipogenesis by Wnt signaling. Science289(5481), 950–953 (2000).
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell125(2), 315–326 (2006).
   PubMed Web of Science ®Google Scholar
• Spira AI, Ettinger DS. The use of chemotherapy in soft-tissue sarcomas. Oncologist7(4), 348–359 (2002).
   PubMed Web of Science ®Google Scholar
• Matushansky I, Maki R, Cordon-Cardo C. A context dependent role for Wnt signaling in tumorigenesis and stem cells. Cell Cycle7(6), 720–724 (2008).
   PubMed Web of Science ®Google Scholar
• Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells: perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res.66(19), 9339–9344 (2006).
   PubMedGoogle Scholar
• Fujii H, Honoki K, Tsujiuchi T et al. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int. J. Oncol.34(5), 1381–1386 (2009).
   PubMed Web of Science ®Google Scholar
• Gibbs CP, Kukekov VG, Reith JD et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia7(11), 967–976 (2005).
   PubMed Web of Science ®Google Scholar
• Jones RJ, Armstrong SA. Cancer stem cells in hematopoietic malignancies. Biol. Blood Marrow Transplant14(Suppl. 1), 12–16 (2008).
   Google Scholar
• Gumucio DL, Fagoonee S, Qiao XT et al. Tissue stem cells and cancer stem cells: potential implications for gastric cancer. Panminerva Med.50(1), 65–71 (2008).
   PubMedGoogle Scholar
• Zhao R, Daley GQ. From fibroblasts to iPS cells: induced pluripotency by defined factors. J. Cell. Biochem.105(4), 949–955 (2008).
   PubMed Web of Science ®Google Scholar
• Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development136(4), 509–523 (2009).
   PubMed Web of Science ®Google Scholar
• Mackall CL, Meltzer PS, Helman LJ. Focus on sarcomas. Cancer Cell2(3), 175–178 (2002).
   PubMed Web of Science ®Google Scholar
• Subramanian S, Lui WO, Lee CH et al. MicroRNA expression signature of human sarcomas. Oncogene27(14), 2015–2026 (2008).
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, Kotsianti A, Verbel DA et al. Improved prediction of prostate cancer recurrence through systems pathology. J. Clin. Invest.117(7), 1876–1883 (2007).
   PubMed Web of Science ®Google Scholar